A meta-analysis of tumor necrosis factor-α and FAS/FASL polymorphisms with risk of pre-eclampsia

References

• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005 Jun 10;308(5728):1592–94. doi:10.1126/science.1111726. PubMed PMID: 15947178.
   PubMed Web of Science ®Google Scholar
• Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. J Pregnancy. 2012;2012:586578. doi:10.1155/2012/586578. PubMed PMID: 22848831; PubMed Central PMCID: PMC3403177.
   PubMedGoogle Scholar
• Al-Jameil N, Aziz Khan F, Fareed Khan M, Tabassum H. A brief overview of preeclampsia. J Clin Med Res. 2014 Feb;6(1):1–7. doi:10.4021/jocmr1682w. PubMed PMID: 24400024; PubMed Central PMCID: PMC3881982.
   PubMedGoogle Scholar
• Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998;16(1):5–15. doi:10.1055/s-2007-1016248. PubMed PMID: 9654603
   PubMedGoogle Scholar
• DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol. 1999 Jul;155(1):293–301. doi:10.1016/S0002-9440(10)65123-1. PubMed PMID: 10393861; PubMed Central PMCID: PMC1866652.
   PubMed Web of Science ®Google Scholar
• Haram K, Mortensen JH, Nagy B. Genetic aspects of preeclampsia and the HELLP syndrome. J Pregnancy. 2014;2014:910751. doi:10.1155/2014/910751. PubMed PMID: 24991435; PubMed Central PMCID: PMC4060423.
   PubMedGoogle Scholar
• Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012 Jan 19;119(3):651–65. doi:10.1182/blood-2011-04-325225. PubMed PMID: 22053109; PubMed Central PMCID: PMC3265196.
   PubMed Web of Science ®Google Scholar
• Huppertz B, Kingdom JC. Apoptosis in the trophoblast–role of apoptosis in placental morphogenesis. J Soc Gynecol Investig. 2004 Sep;11(6):353–62. doi:10.1016/j.jsgi.2004.06.002. PubMed PMID: 15350247.
   PubMedGoogle Scholar
• Raghupathy R. Cytokines as key players in the pathophysiology of preeclampsia. Med Princ Pract. 2013;22(Suppl 1):8–19. doi:10.1159/000354200. PubMed PMID: 23949305; PubMed Central PMCID: PMC5586811
   PubMed Web of Science ®Google Scholar
• Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN, Bennett WA. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol. 1999 Oct;181(4):915–20. PubMed PMID: 10521753.
   PubMed Web of Science ®Google Scholar
• Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol. 1996 Apr;104(1):154–59. PubMed PMID: 8603520; PubMed Central PMCID: PMC2200396.
   PubMed Web of Science ®Google Scholar
• Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol. 1994 Jun;170(6):1752–59. PubMed PMID: 8203436.
   PubMed Web of Science ®Google Scholar
• Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knöfler M. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab. 2004 Feb;89(2):812–22. doi:10.1210/jc.2003-031351. PubMed PMID: 14764800.
   PubMed Web of Science ®Google Scholar
• Mor G, Straszewski S, Kamsteeg M. Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis. Biochem Pharmacol. 2002 Nov 1;64(9):1305–15. PubMed PMID: 12392813.
   PubMed Web of Science ®Google Scholar
• Mor G, Gutierrez LS, Eliza M, Kahyaoglu F, Arici A. Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am J Reprod Immunol. 1998 Aug;40(2):89–94. PubMed PMID: 9764350.
   PubMed Web of Science ®Google Scholar
• Levesque S, Moutquin JM, Lindsay C, Roy M-C, Rousseau F. Implication of an AGT haplotype in a multigene association study with pregnancy hypertension. Hypertension. 2004 Jan;43(1):71–78. doi:10.1161/01.HYP.0000104525.76016.77. PubMed PMID: 14638622.
   PubMed Web of Science ®Google Scholar
• Tavakkol Afshari Z, Rahimi HR, Ehteshamfar SM, Ganjali R, Tara F, Shapouri Moghadam A. Tumor necrosis factor-alpha and interleukin-1-beta polymorphisms in pre-eclampsia. IJI. 2016 Dec;13(4):309–16. doi: IJIv13i4A7. PubMed PMID: 27999242.
   Web of Science ®Google Scholar
• Mirahmadian M, Kalantar F, Heidari G, Safdarian L, Mansouri R, Amirzargar AA. Association of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Iranian patients with pre-eclampsia. Am J Reprod Immunol. 2008 Aug;60(2):179–85. doi:10.1111/j.1600-0897.2008.00610.x. PubMed PMID: 18705845.
   PubMed Web of Science ®Google Scholar
• Mohajertehran F, Tavakkol Afshari J, Rezaieyazdi Z, Ghomian N. Association of single nucleotide polymorphisms in the human tumor necrosis factor-alpha and interleukin 1-beta genes in patients with pre-eclampsia. Iran J Allergy Asthma Immunol. 2012 Sep;11(3):224–29. doi:10.011.03/ijaai.224229. PubMed PMID: 22947907.
   PubMed Web of Science ®Google Scholar
• Xie C, Yao MZ, Liu JB, Xiong LK. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine. 2011 Dec;56(3):550–59. doi:10.1016/j.cyto.2011.09.021. PubMed PMID: 22019000.
   PubMed Web of Science ®Google Scholar
• Bombell S, McGuire W. Tumour necrosis factor (−308A) polymorphism in pre-eclampsia: meta-analysis of 16 case-control studies. Aust N Z J Obstet Gynaecol. 2008 Dec;48(6):547–51. doi:10.1111/j.1479-828X.2008.00924.x. PubMed PMID: 19133041.
   PubMed Web of Science ®Google Scholar
• Pinheiro MB, Gomes KB, Ronda CR, Guimarães GG, Freitas LG, Teixeira-Carvalho A, Martins-Filho OA, Dusse LM. Severe preeclampsia: association of genes polymorphisms and maternal cytokines production in Brazilian population. Cytokine. 2015 Feb;71(2):232–37. doi:10.1016/j.cyto.2014.10.021. PubMed PMID: 25461403.
   PubMed Web of Science ®Google Scholar
• Zubor P, Dokus K, Zigo I, Skerenova M, Pullmann R, Danko J. TNF alpha G308A gene polymorphism has an impact on renal function, microvascular permeability, organ involvement and severity of preeclampsia. Gynecol Obstet Invest. 2014;78(3):150–61. doi:10.1159/000364865. PubMed PMID: 25059926
   PubMed Web of Science ®Google Scholar
• Zhou L, Cheng L, He Y, Gu Y, Wang Y, Wang C. Association of gene polymorphisms of FV, FII, MTHFR, SERPINE1, CTLA4, IL10, and TNFalpha with pre-eclampsia in Chinese women. Inflamm Res. 2016 Sep;65(9):717–24. doi:10.1007/s00011-016-0953-y. 10.1007/s00011-016-0953-y. PubMed PMID: 27233255.
   PubMed Web of Science ®Google Scholar
• Gao L-B, Pan X-M, Li L-J, Liang W-B, Zhu Y, Zhang L-S, Wei Y-G, Tang M, Zhang L. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat. 2011 Feb;125(3):827–35. doi:10.1007/s10549-010-0995-8. PubMed PMID: 20640595; eng.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun 15;21(11):1539–58. doi:10.1002/sim.1186. PubMed PMID: 12111919; eng.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–48. PubMed PMID: 13655060; eng.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–88. 0197-2456(86)90046-2 [pii]. PubMed PMID: 3802833; eng.
   PubMedGoogle Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629–34. PubMed PMID: 9310563; PubMed Central PMCID: PMC2127453. eng.
   PubMed Web of Science ®Google Scholar
• Daher S, Sass N, Oliveira LG, Mattar R. Cytokine genotyping in preeclampsia. Am J Reprod Immunol. 2006 Feb;55(2):130–35. doi:10.1111/j.1600-0897.2005.00341.x. PubMed PMID: 16433832.
   PubMed Web of Science ®Google Scholar
• Haggerty CL, Ferrell RE, Hubel CA, Markovic N, Harger G, Ness RB. Association between allelic variants in cytokine genes and preeclampsia. Am J Obstet Gynecol. 2005 Jul;193(1):209–15. doi:10.1016/j.ajog.2004.11.008. PubMed PMID: 16021081.
   PubMed Web of Science ®Google Scholar
• Lasabova Z, Zigo I, Svecova I, Szabo G, Stanclova A, Skerenova M, et al. Association of specific diplotypes defined by common rs1800682 and rare rs34995925 single nucleotide polymorphisms within the STAT1 transcription binding site of the FAS gene promoter with preeclampsia. Gen Physiol Biophys. 2014;33(2):199–204. doi:10.4149/gpb_2013081. PubMed PMID: 24448373
   PubMed Web of Science ®Google Scholar
• Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2001 May;184(6):1249–50. doi:10.1067/mob.2001.112906. PubMed PMID: 11349196.
   PubMed Web of Science ®Google Scholar
• Neale DM, Mor G. The role of Fas mediated apoptosis in preeclampsia. J Perinat Med. 2005;33(6):471–77. doi:10.1515/JPM.2005.085. PubMed PMID: 16318609
   PubMed Web of Science ®Google Scholar
• Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol. 2000 Aug;96(2):271–76. PubMed PMID: 10908776.
   PubMed Web of Science ®Google Scholar
• Wang CY, Mayo MW, Baldwin AS Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 1996 Nov 1;274(5288):784–87. PubMed PMID: 8864119.
   PubMed Web of Science ®Google Scholar
• Lau SY, Guild SJ, Barrett CJ, Chen Q, McCowan L, Jordan V, Chamley LW. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol. 2013 Nov;70(5):412–27. doi:10.1111/aji.12138. PubMed PMID: 23790133.
   PubMed Web of Science ®Google Scholar
• Skjaerven R, Vatten LJ, Wilcox AJ, Andersen LB, Sardinha LB, Riddoch CJ, et al. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. Bmj. 2005 Oct 15;331(7521):877. doi:10.1136/bmj.38555.462685.8F. PubMed PMID: 16169871; PubMed Central PMCID: PMC1255793.
   PubMed Web of Science ®Google Scholar
• Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, Sato T, Reed JC, Green D, Swain SL. Unequal death in T helper cell (Th)1 and Th2 effectors: th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med. 1997 May 19;185(10):1837–49. PubMed PMID: 9151709; PubMed Central PMCID: PMC2196321.
   PubMed Web of Science ®Google Scholar
• Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab. 1997 Sep;82(9):3173–75. doi:10.1210/jcem.82.9.4360. PubMed PMID: 9284765.
   PubMed Web of Science ®Google Scholar
• Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993 Jul;14(7):353–56. doi:10.1016/0167-5699(93)90235-D. PubMed PMID: 8363725.
   PubMedGoogle Scholar
• Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1: th2cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol. 1999 Sep;117(3):550–55. PubMed PMID: 10469061; PubMed Central PMCID: PMC1905376.
   PubMed Web of Science ®Google Scholar
• Miko E, Szereday L, Barakonyi A, Jarkovich A, Varga P, Szekeres-Bartho J. Immunoactivation in preeclampsia: vdelta2+ and regulatory T cells during the inflammatory stage of disease. J Reprod Immunol. 2009 Jun;80(1–2):100–08. doi:10.1016/j.jri.2009.01.003. PubMed PMID: 19395088.
   PubMed Web of Science ®Google Scholar
• Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol. 2003 Aug;59(2):161–73. PubMed PMID: 12896820.
   PubMed Web of Science ®Google Scholar
• Behrmann I, Walczak H, Krammer PH. Structure of the human APO-1 gene. Eur J Immunol. 1994 Dec;24(12):3057–62. doi:10.1002/eji.1830241221. PubMed PMID: 7528667.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol. 1994 Oct;6(10):1567–74. PubMed PMID: 7826947.
   PubMed Web of Science ®Google Scholar
• Pinti M, Troiano L, Nasi M, Moretti L, Monterastelli E, Mazzacani A, et al. Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians. Cell Death Differ. 2002 Apr;9(4):431–38. doi:10.1038/sj/cdd/4400964. PubMed PMID: 11965496.
   PubMed Web of Science ®Google Scholar
• Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC, Cooke J, Xie F, Cooper GS, Kimberly RP. A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunology. 2003 Jan 1;170(1):132–38. doi:10.4049/jimmunol.170.1.132. PubMed PMID: 12496392.
   PubMed Web of Science ®Google Scholar